Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN)

Historical Holders from Q2 2021 to Q3 2025

Symbol
DAWN on Nasdaq
CUSIP
23954D109
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
101M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
86.2M
Holdings value
$560M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
173
Number of buys
97
Number of sells
-88
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 11.2% -12.3% $73.2M -$9.96M 11.3M -12% FMR LLC Jun 30, 2025
BlackRock, Inc. 5.8% +22% $37.7M $6.69M 5.85M +21.6% BlackRock, Inc. Jun 30, 2025

Institutional Holders of Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 39 $275 -$21.6K $7.05 1
2025 Q2 86.2M $560M -$67.6M $6.50 173
2025 Q1 94.1M $746M -$40.5M $7.93 183
2024 Q4 93.7M $1.19B -$3.74M $12.67 163
2024 Q3 91.9M $1.28B +$237M $13.93 165
2024 Q2 74.6M $1.03B +$21.2M $13.78 154
2024 Q1 72.6M $1.2B -$58.7M $16.52 145
2023 Q4 102K $1.5M +$113K $14.60 3
2023 Q3 77.3M $949M -$24.3M $12.27 124
2023 Q2 78.6M $938M +$206M $11.94 133
2023 Q1 61.1M $816M -$9.34M $13.37 119
2022 Q4 59.8M $1.29B -$37.7M $21.52 102
2022 Q3 60.2M $1.21B +$22M $20.03 84
2022 Q2 59.3M $1.06B +$302M $17.90 79
2022 Q1 43.3M $430M +$13.1M $9.92 65
2021 Q4 41.5M $698M +$74.6M $16.85 56
2021 Q3 19M $450M +$33.8M $23.73 44
2021 Q2 17.7M $401M +$401M $22.77 32